Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday
Gainers
Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.
Enzo Biochem Q3 EPS $(0.10) Down From $0.04 YoY, Sales $26.20M Down From $32.80M YoY
Enzo Biochem (NYSE:ENZ) reported quarterly losses of $(0.10) per share. This is a 350 percent decrease over earnings of $0.04 per share from the same period last year. The company reported $26.20 million in sales this
Earnings Scheduled For June 9, 2022
Companies Reporting Before The Bell
• Aurora Mobile (NASDAQ:JG) is likely to report quarterly loss at $0.05 per share on revenue of $14.64 million.
The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More
Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended.
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 211 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday, 581 stocks hit new 52-week lows.
Interesting Highlights From Today's 52-Week Lows
Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
Enzo Biochem Reports New York State Dept. Of Health Approval For Its Human Papillomavirus Molecular Diagnostic Test
Approval adds HPV to menu of tests available on Enzo’s GenFlex® platform, which includes COVID-19 PCR and CT/NG/TV
NEW YORK, NY, April 19, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ)
Enzo Biochem Q2 EPS $0.03 Down From $0.09 YoY, Sales $34.05M Up From $31.47M YoY
Enzo Biochem (NYSE:ENZ) reported quarterly earnings of $0.03 per share. This is a 66.67 percent decrease over earnings of $0.09 per share from the same period last year. The company reported $34.05 million in sales this
Earnings Scheduled For March 14, 2022
Companies Reporting Before The Bell
• F45 Training Holdings (NYSE:FXLV) is projected to report earnings for its fourth quarter.